Synergy in natural medicines: implications for drug discovery
Authors:
- Xue-Juan LiXLXue-Juan Li
- Hong-Yu ZhangHZHong-Yu Zhang
- 1 July 2008
- journal article
- other
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 29 (7) , 331-332
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemiaProceedings of the National Academy of Sciences, 2008
- Western-medicine-validated anti-tumor agents and traditional Chinese medicineTrends in Molecular Medicine, 2008
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- A culture in the balanceNature, 2007
- Why has R&D productivity declined in the pharmaceutical industry?Expert Opinion on Drug Discovery, 2006
- Multicomponent therapeutics for networked systemsNature Reviews Drug Discovery, 2005
- Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsiesBiochemical and Biophysical Research Communications, 2004
- Immunosuppressive and Anti-Inflammatory Mechanisms of Triptolide, the Principal Active Diterpenoid from the Chinese Medicinal Herb Tripterygium wilfordii Hook. f.Drugs in R&D, 2003
- Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitorProceedings of the National Academy of Sciences, 2000
- The long term efficacy of glycyrrhizin in chronic hepatitis C patientsCancer, 1997